Related Experiment Video
Updated: May 6, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
15.6K
Therapeutic botulinum toxin preparations: an update.
Hans Bigalke1, Jürgen Frevert2, Dirk Dressler3,4
1Toxogen, Hannover, Germany.
Summary
This review details botulinum neurotoxin (BoNT) formulations, including complex-free options like IncobotulinumtoxinA (INCO), DaxibotulinumtoxinA (DAXI), and RelabotulinumtoxinA (RELA). It covers excipients, stabilization methods, and emerging BoNT types for therapeutic and aesthetic uses.
Area of Science:
- Neurology
- Pharmacology
- Biochemistry
Background:
- Botulinum neurotoxin (BoNT) is widely used for therapeutic and aesthetic purposes, with many off-label applications.
- Current BoNT preparations include the active neurotoxin, complexing proteins, and excipients, though newer formulations are complex-free.
Purpose of the Study:
- To review the composition, formulation, and emerging developments of botulinum neurotoxin drugs.
- To compare different BoNT formulations, including complex-free and ready-to-use liquid preparations.
Main Methods:
- Literature review of existing botulinum neurotoxin products and ongoing research.
- Analysis of BoNT formulations, including excipients, stabilization techniques, and storage conditions.
Main Results:
- IncobotulinumtoxinA (INCO), DaxibotulinumtoxinA (DAXI), and RelabotulinumtoxinA (RELA) are complex-free formulations.
- Liquid preparations and room temperature storage are emerging trends.
- BoNT type B and E present unique profiles, with recombinant and hybrid types under development.
Conclusions:
- The field of BoNT therapeutics is evolving with complex-free, liquid, and novel type formulations.
- Understanding these variations is crucial for optimizing therapeutic and aesthetic outcomes.
Keywords:
Botulinum toxinBotulinum toxin type ABotulinumtoxin type BBotulinumtoxin type EExcipientsFormulationPharmacologyStorageTherapeutic preparationsMore Related Videos
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
2.2K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
1.7K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.7K
01:21Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K
01:26Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
01:28Classification of Skeletal Muscle Relaxants
3.6K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.6K